NEW YORK, March 27 – Spectral Genomics of Houston launched Tuesday its SpectralChip Human BAC Arrays.

The company said its Human SpectralChip Microarray Kit comes with two arrays with 1,003 non-overlapping BAC clones from the RPCI BAC library, which are spotted in duplicate. The kit also includes reagents and solutions for labeling and hybridization. The BACs span the genome at approximately 3mb intervals, thus only enabling the detection of aberrations greater than 3mb.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.